Código QR

Prediction of FLAG ± Ida Regimen Efficacy in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Aim. To assess the efficacy of FLAG/FLAG-Ida regimen and to identify factors that influence remission, duration of disease-free survival (DFS) and overall survival (OS) of patients with relapsed/refractory acute myeloid leukemia (AML). Materials & Methods. The trial included 54 patients (28 men a...

Descrición completa

Gardado en:
Principais autores: Irina Garmaevna Budaeva, E. G. Ovsyannikova, E. N. Goryunova, O. V. Kulemina, D. V. Zaitsev, D. V. Motorin, R. Sh. Badaev, D. B. Zammoeva, V. V. Ivanov, K. V. Bogdanov, O. S. Pisotskaya, Yu. V. Mirolyubova, T. S. Nikulina, Yu. A. Alekseeva, A. Yu. Zaritskey, L. L. Girshova
Formato: Artigo
Idioma:Russo
Publicado: Practical Medicine Publishing House 2019-07-01
Series:Клиническая онкогематология
Assuntos:
acute myeloid leukemia
relapse
refractoriness
flag and flag-ida regimens
Acceso en liña:https://bloodjournal.ru/index.php/coh/article/view/323
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares